Your browser is no longer supported. Please, upgrade your browser.
Brookline Capital Acquisition Corp.
Index- P/E- EPS (ttm)-0.06 Insider Own- Shs Outstand7.43M Perf Week0.20%
Market Cap73.93M Forward P/E- EPS next Y- Insider Trans- Shs Float7.43M Perf Month0.10%
Income-0.50M PEG- EPS next Q- Inst Own32.30% Short Float0.03% Perf Quarter1.17%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.25 Perf Half Y0.61%
Book/sh7.82 P/B1.27 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.05 P/C184.82 EPS next 5Y- ROE- 52W Range9.11 - 11.07 Perf YTD-6.57%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-10.12% Beta-
Dividend %- Quick Ratio4.20 Sales past 5Y- Gross Margin- 52W Low9.22% ATR0.03
Employees- Current Ratio4.20 Sales Q/Q- Oper. Margin- RSI (14)52.77 Volatility0.15% 0.28%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.39 Prev Close9.95
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume9.98K Price9.95
Recom- SMA200.06% SMA500.24% SMA2000.33% Volume2,660 Change0.00%
Brookline Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the life sciences industry. The company was founded in 2020 and is based in New York, New York.